Mexico Cyclooxygenase 2 Inhibitor Market (2025-2031) | Value, Competitive Landscape, Share, Size & Revenue, Outlook, Trends, Companies, Segmentation, Forecast, Industry, Growth, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Mexico Country Macro Economic Indicators

3.2 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, 2021 & 2031F

3.3 Mexico Cyclooxygenase 2 Inhibitor Market - Industry Life Cycle

3.4 Mexico Cyclooxygenase 2 Inhibitor Market - Porter's Five Forces

3.5 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Types, 2021 & 2031F

3.7 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.8 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.9 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases such as arthritis and cancer requiring long-term pain management.

4.2.2 Growing geriatric population in Mexico with higher susceptibility to musculoskeletal disorders.

4.2.3 Rising awareness about the benefits of using cyclooxygenase 2 inhibitors over traditional NSAIDs.

4.3 Market Restraints

4.3.1 Stringent regulatory environment surrounding the approval and marketing of pharmaceutical products in Mexico.

4.3.2 Presence of generic alternatives and OTC pain relievers affecting the market share of cyclooxygenase 2 inhibitors.

4.3.3 Concerns regarding potential side effects and safety issues associated with long-term use of cyclooxygenase 2 inhibitors.

6.1 Mexico Cyclooxygenase 2 Inhibitor Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Celecoxib, 2021- 2031F

6.1.4 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rofecoxib, 2021- 2031F

6.1.5 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Valdecoxib, 2021- 2031F

6.1.6 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Amlodipine, 2021- 2031F

6.1.7 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F

6.2 Mexico Cyclooxygenase 2 Inhibitor Market, By Types

6.2.1 Overview and Analysis

6.2.2 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Selective cox 2 inhibitor, 2021- 2031F

6.2.3 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Non-selective cox 2 inhibitor, 2021- 2031F

6.3 Mexico Cyclooxygenase 2 Inhibitor Market, By Indication

6.3.1 Overview and Analysis

6.3.2 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Osteoarthritis, 2021- 2031F

6.3.3 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rheumatoid arthritis, 2021- 2031F

6.3.4 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F

6.4 Mexico Cyclooxygenase 2 Inhibitor Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.4 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F

6.5 Mexico Cyclooxygenase 2 Inhibitor Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.5.4 Mexico Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F

7.1 Mexico Cyclooxygenase 2 Inhibitor Market Export to Major Countries

7.2 Mexico Cyclooxygenase 2 Inhibitor Market Imports from Major Countries

8.1 Prescription refill rates for cyclooxygenase 2 inhibitors.

8.2 Number of clinical trials focusing on the efficacy and safety profile of these inhibitors.

8.3 Patient adherence rates to prescribed cyclooxygenase 2 inhibitor regimens.

8.4 Percentage of physicians recommending cyclooxygenase 2 inhibitors as first-line treatment for pain management.

9.1 Mexico Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Mexico Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Types, 2021 & 2031F

9.3 Mexico Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Indication, 2021 & 2031F

9.4 Mexico Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.5 Mexico Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Mexico Cyclooxygenase 2 Inhibitor Market Revenue Share, By Companies, 2024

10.2 Mexico Cyclooxygenase 2 Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters